KPJ Healthcare Berhad’s second quarter Profit After Tax jumped to RM48.5 million and Profit Before Tax achieved RM68.5 million as compared to RM30.5 million and RM46.2 million in the second quarter of Financial Year 2022.
Revenue came in at RM799.5 million, a 14.3% increase from Q2 FY2022. The Group’s Earnings Before Interest, Taxes, Depreciation, and Amortisation showed a commendable 16.8% growth amounting to RM185.1 million, compared to RM158.4 million during Q2 FY2022. This achievement was largely attributed to a significant rise in inpatients, totalling 82,479, up from 72,424. Bed Occupancy Rate (“BOR”) improved to 63% from 56% during the same period last year.
Cumulatively for the first six months of the financial year 2023 (“1H FY2023”), both PAT and PBT increased to RM104.9 million and RM146.2 million respectively compared to the corresponding period last year. The Group’s total revenue witnessed a robust growth of 21.4%, reaching RM1.6 billion, up from RM1.3 billion during 1H FY2022. KPJ Healthcare also reported a 21.6% leap in EBITDA amounting to RM375.3 million, compared to RM308.7 million in the corresponding period last year.
KPJ Healthcare declared an interim dividend of 0.8 sen per share, with a total aggregate payment of RM34.9 million, to be disbursed to the shareholders of KPJ Healthcare on 3 October 2023.
